Status:
COMPLETED
Safety Surveillance Study of ACAM2000® Vaccinia Vaccine
Lead Sponsor:
Emergent BioSolutions
Conditions:
Smallpox
Eligibility:
All Genders
17+ years
Brief Summary
This is an enhanced safety surveillance study that will occur within the military Service Member population. Primary Objective: * To evaluate the rates of suspected, probable, and confirmed myocardi...
Detailed Description
The Armed Forces Health Surveillance Activity (AFHSA) will perform comprehensive health surveillance through the operation of the Defense Medical Surveillance System (DMSS). Demographic and medical in...
Eligibility Criteria
Inclusion
- Inclusion Criteria :
- Male and female military personnel \>= 17 years of age.
- Have received the ACAM2000® smallpox vaccine.
- Exclusion Criteria :
- Not applicable.
Exclusion
Key Trial Info
Start Date :
December 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2017
Estimated Enrollment :
897227 Patients enrolled
Trial Details
Trial ID
NCT00927719
Start Date
December 1 2008
End Date
December 31 2017
Last Update
March 18 2024
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Twentynine Palms, California, United States, 92278
2
Fort Campbell North, Kentucky, United States, 42223
3
Fort Bliss, Texas, United States, 79906
4
Fort Hood, Texas, United States, 76544